RSS   Newsletter   Contact   Advertise with us
Post Online Media

Jaguar Animal Health appoints chief scientific officer

Jaguar Animal HealthJaguar Animal Health, an animal medicine company, announced that it has appointed Roger Waltzman as chief scientific officer.
Article continues below

READ MORE Aratana appoints Brent A. Standridge as COO

Dr. Waltzman is a human medical oncologist and experienced drug-development executive.

He spent over 10 years in academic clinical oncology practice at Memorial Sloan-Kettering, Mount Sinai, and Saint Vincent hospitals in New York, and nine years in drug development with Novartis Pharmaceuticals, leading successful NDA and sNDA filings for Glivec, Tasigna, and Jakavi, and serving most recently as Head of Development for anti-malarials at Novartis.

Dr. Waltzman earned his MD degree from Brown University School of Medicine and completed internal medicine training at Beth Israel Hospital in Boston, as well as a fellowship in hematology/oncology at Memorial Sloan-Kettering Cancer Center in New York City. He is board certified in medical oncology.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy